Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 24Neoplasm Metastasis 7Neoplasms 5Prostate Cancer Metastatic 4Carcinoma, Transitional Cell 4Recurrence 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Solid Cancer 1Small Cell Lung Carcinoma 1Penile Neoplasms 1Ovarian Neoplasms 1Nonseminomatous germ cell tumor 1Neoplastic Cells, Circulating 1Metastatic Castration-resistant Prostate Cancer 1Malignant Solid Tumor - Malignant Nervous System Neoplasm 1Lymphadenopathy 1Liposarcoma 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Breast Neoplasms 1Bone Metastatic Prostate Cancer 1Advanced Solid Tumor 1

Interventions

Prednisone 5enzalutamide 4cabazitaxel 4Docetaxel 3XRP6258 2Abiraterone Acetate 2sipuleucel-T 1rucaparib 1olaparib 1apalutamide 1Zuclomiphene 1Standard of Care 1Prednisolone 1Lenograstim 1LY3023414 1Injections 1Hematologic Tests 1Granulocyte Colony-Stimulating Factor 1Abituzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Prostate Cancer Metastatic × cabazitaxel × Clear all
NCT02485691 2022-05-27

CARD

Sanofi

Phase 4 Completed
255 enrolled 21 charts
Genitourinary

Prostate Cancer Metastatic

NCT02961257 2022-05-12

CABASTY

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Phase 3 Completed
196 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT01718353 2017-11-20

TAXYNERGY

Sanofi

Phase 2 Completed
63 enrolled 13 charts
Genitourinary

Prostate Cancer Metastatic

NCT01254279 2015-01-21

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Sanofi

Phase 3 Completed
984 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡